miconazole has been researched along with Co-infection in 5 studies
Miconazole: An imidazole antifungal agent that is used topically and by intravenous infusion.
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole : A member of the class of imidazoles that is 1-(2,4-dichlorophenyl)-2-(imidazol-1-yl)ethanol in which the hydroxyl hydrogen is replaced by a 2,4-dichlorobenzyl group.
miconazole : A racemate composed of equimolar amounts of (R)- and (S)-miconazole. Used (as its nitrate salt) to treat skin infections such as athlete's foot, jock itch, ringworm and other fungal skin infections. It inhibits the synthesis of ergosterol, a critical component of fungal cell membranes.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The rapid improvement observed with Travocort treatment, combined with favourable safety and tolerability, results in higher patient satisfaction, and therefore, can be an effective tool to increase treatment adherence in patients with dermatomycoses accompanied by inflammatory signs and symptoms." | 2.49 | Isoconazole nitrate: a unique broad-spectrum antimicrobial azole effective in the treatment of dermatomycoses, both as monotherapy and in combination with corticosteroids. ( Veraldi, S, 2013) |
| "Isoconazole nitrate has a broad bacteriostatic and bactericidal action, also against a MRSA strain that was not reduced by the corticosteroid in the Travocort cream." | 1.39 | Reactive oxygen species and the bacteriostatic and bactericidal effects of isoconazole nitrate. ( Czaika, VA; Czekalla, F; Siebenbrock, J; Sieber, MA; Zuberbier, T, 2013) |
| "Cutaneous candidiasis is a disease that affects children as well as adults." | 1.38 | [Generalized cutaneous candidiasis in newborn at term]. ( Cañadas-De la Fuente, GA; Cantero-Hinojosa, J; El Ahmed, HH; Fernández-Castillo, R; González-Jiménez, E; Lardón-Fernández, M, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Veraldi, S | 2 |
| Czaika, VA | 1 |
| Siebenbrock, J | 1 |
| Czekalla, F | 1 |
| Zuberbier, T | 1 |
| Sieber, MA | 1 |
| Kamikawa, Y | 1 |
| Mori, Y | 1 |
| Nagayama, T | 1 |
| Fujisaki, J | 1 |
| Hirabayashi, D | 1 |
| Sakamoto, R | 1 |
| Hamada, T | 1 |
| Sugihara, K | 1 |
| El Ahmed, HH | 1 |
| Cañadas-De la Fuente, GA | 1 |
| Fernández-Castillo, R | 1 |
| González-Jiménez, E | 1 |
| Cantero-Hinojosa, J | 1 |
| Lardón-Fernández, M | 1 |
1 review available for miconazole and Co-infection
| Article | Year |
|---|---|
Isoconazole nitrate: a unique broad-spectrum antimicrobial azole effective in the treatment of dermatomycoses, both as monotherapy and in combination with corticosteroids.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antifungal Agents; Coinfection; Dermatomycoses; Dif | 2013 |
4 other studies available for miconazole and Co-infection
| Article | Year |
|---|---|
The benefits of combination therapy in dermatomycoses.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antifungal Agents; Coinfection; Dermatomycoses; Dif | 2013 |
Reactive oxygen species and the bacteriostatic and bactericidal effects of isoconazole nitrate.
Topics: Ampicillin; Anti-Bacterial Agents; Antifungal Agents; Coinfection; Dermatomycoses; Gram-Positive Bac | 2013 |
Frequency of clinically isolated strains of oral Candida species at Kagoshima University Hospital, Japan, and their susceptibility to antifungal drugs in 2006-2007 and 2012-2013.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Autoimmune Diseases; Bacterial Lo | 2014 |
[Generalized cutaneous candidiasis in newborn at term].
Topics: Administration, Cutaneous; Administration, Oral; Anti-Infective Agents; Bacteremia; Bicarbonates; Ca | 2012 |